Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents

Mavel S, Mincheva Z, Méheux N, Carcenac Y, Guilloteau D, Abarbri M (2012) QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT). Bioorg Med Chem 20(4):1388–1395

Olasupo SB, Uzairu A, Shallangwa GA, Uba S (2020) Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents. Heliyon 6(7):e04464

Li P, Snyder GL, Vanover KE (2016) Dopamine targeting drugs for the treatment of schizophrenia: past, present and future. Curr Top Med Chem 16(29):3385–3403

Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J (2017) A novel dopamine transporter inhibitor CE-123 improves cognitive flexibility and maintains impulsivity in healthy male rats. Front Behav Neurosci 11:222

Dolder PC, Müller F, Schmid Y, Borgwardt SJ, Liechti ME (2018) Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects. Psychopharmacology 235(2):467–479

Gong L, Yin Y, He C, Ye Q, Bai F, Yuan Y (2017) Disrupted reward circuits is associated with cognitive deficits and depression severity in major depressive disorder. J Psychiatr Res 84:9–17

Stroup TS, Marder S (2015) Pharmacotherapy for schizophrenia: acute and maintenance phase treatment. UptoDate July

Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Molecules. 20(7):13384–13421

Hehre WJ, Huang WW (1995) Chemistry with computation: an introduction to SPARTAN. Wavefunction, Inc, Irvine

Olasupo SB, Uzairu A, Shallangwa GA, Uba S (2020) Profiling the antidepressant properties of Phenyl piperidine derivatives as inhibitors of serotonin transporter (SERT) via cheminformatics modeling, molecular docking and ADMET predictions. Sci Afr 9:e00517

Lipinski CA (2016) Rule of five in 2015 and beyond: target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Deliv Rev 101:34–41

Penmatsa A, Wang KH, Gouaux E (2013) X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503(7474):85–90. https://doi.org/10.1038/nature12533

Babatunde S, Adamu O, Gideon U, Sani S (2020) QSAR modeling , molecular docking and ADMET / pharmacokinetic studies : a chemometrics approach to search for novel inhibitors of norepinephrine transporter as potent antipsychotic drugs. J Iran Chem Soc 17(8):1953–1966. https://doi.org/10.1007/s13738-020-01902-5

ul Hassan SS, Zhang W-D, Jin H, Basha SH, Priya SVSS (2020) In-silico anti-inflammatory potential of guaiane dimers from Xylopia vielana targeting COX-2. J Biomol Struct Dyn 1:1–15. https://doi.org/10.1080/07391102.2020.1815579

Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https://doi.org/10.1038/srep42717

Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z (2019) admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35(6):1067–1069

Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58(9):4066–4072

Cheminformatics M (2018) Calculation of molecular properties and bioactivity score. Comput software] Retrieved from http://www.molinspiration.com/cgi-bin/properties.

Qing X, Lee XY, De Raeymaecker J, Tame JRH, Zhang KYJ, De Maeyer M (2014) Pharmacophore modeling: advances, limitations, and current utility in drug discovery. J Receptor Ligand Channel Res 7:81–92

Rawn JD, Ouellette RJ (2018) Organic chemistry: structure, mechanism, synthesis. Academic Press, Cambridge

Mpiana PT, Tshibangu DST, Kilembe JT, Gbolo BZ, Mwanangombo DT, Inkoto CL (2020) Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: a molecular docking study. Chem Phys Lett 754:137751

Ye Z, Yang Y, Li X, Cao D, Ouyang D (2018) An integrated transfer learning and multitask learning approach for pharmacokinetic parameter prediction. Mol Pharm 16(2):533–541

Hassan M, Ashraf Z, Abbas Q, Raza H, Seo S-Y (2018) Exploration of novel human tyrosinase inhibitors by molecular modeling, docking and simulation studies. Interdiscip Sci Comput Life Sci 10(1):68–80

Aswathy L, Jisha RS, Masand VH, Gajbhiye JM, Shibi IG (2018) Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction. In Silico Pharmacol 6(1):12

Olasupo SB, Uzairu A, Adamu GS, Uba S (2020) Computational modeling and pharmacokinetics/ADMET study of some arylpiperazine derivatives as novel antipsychotic agents targeting depression. Chem Afr 3:1–10

Daina A, Zoete V (2016) A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11(11):1117–1121

Roy S, Samant LR, Chowdhary A (2015) In silico pharmacokinetics analysis and ADMET of phytochemicals of Datura metel Linn. and Cynodon dactylon Linn. J Chem Pharm Res 7:385–388

Ertl P, Schuffenhauer A (2009) Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminform 1(1):8

dos Santos KLB, Cruz JN, Silva LB, Ramos RS, Neto MFA, Lobato CC (2020) Identification of novel chemical entities for adenosine receptor type 2A using molecular modeling approaches. Molecules 25(5):1245